Rallybio Corporation Common Stock (RLYB)
Stock · NASDAQ · Health Care
$16.28as of 10/16/2026
Price chart
Active signals
No technical signal is currently active for this symbol.
RLYB Signal Track Record
How signals performed across all stocks →What RLYB's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 28 | +2.6% | 54% | July 13, 2026 |
| Bollinger Band Breakout | 24 | -1.5% | 46% | September 15, 2026 |
| Bollinger Band Breakdown | 20 | -7.0% | 30% | September 14, 2026 |
| 200-Day Moving Average Touch | 8 | -12.3% | 38% | February 17, 2026 |
| Any 20-session window (baseline) | -0.9% | 47% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About RLYB
Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the tre…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 7
- Website
- www.rallybio.com
Fundamentals
- 1-day range
- $16.86$17.2
- Market cap
- $85.78M
- P/E (trailing)
- 2.13
- P/E (forward)
- -3.15
- EPS (trailing)
- $7.99
- Dividend yield
- —
- Beta
- -0.86
- Avg. volume
- 47.7K
How Rallybio Corporation Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 16, 2026 · via SEC EDGAR / Finnhub
Rallybio Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- RLYBRallybio Corporation Common Stock$16.28▼ 2.95%Market cap $85.78MP/E 2.13$3.67$17.57
- MAIAMAIA Biotechnology Inc. Common Stock$1.1▼ 1.79%Market cap $86.34MP/E —$0.87$3.19
- GOSSGossamer Bio Inc. Common Stock$8.77▼ 1.35%Market cap $87.21MP/E —$8.77$309.6
- LFVNLifevantage Corporation Common Stock (Delaware)$6▲ 0.00%Market cap $83.01MP/E 14.40$3.9$11.71
- ATHEAlterity Therapeutics Limited American Depositary Shares$2.62▼ 3.68%Market cap $82.65MP/E —$0.01$0.785
- BMEABiomea Fusion Inc. Common Stock$0.869▲ 3.95%Market cap $90.37MP/E —$0.800501$2.24
- NTHINeOnc Technologies Holdings Inc. Common Stock$2.7▼ 1.82%Market cap $90.77MP/E —$2.5$12
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| RLYB Rallybio Corporation Common Stock | $85.78M | 2.13 | $16.28 | ▼ 2.95% | $3.67$17.57 |
| MAIA MAIA Biotechnology Inc. Common Stock | $86.34M | — | $1.1 | ▼ 1.79% | $0.87$3.19 |
| GOSS Gossamer Bio Inc. Common Stock | $87.21M | — | $8.77 | ▼ 1.35% | $8.77$309.6 |
| LFVN Lifevantage Corporation Common Stock (Delaware) | $83.01M | 14.40 | $6 | ▲ 0.00% | $3.9$11.71 |
| ATHE Alterity Therapeutics Limited American Depositary Shares | $82.65M | — | $2.62 | ▼ 3.68% | $0.01$0.785 |
| BMEA Biomea Fusion Inc. Common Stock | $90.37M | — | $0.869 | ▲ 3.95% | $0.800501$2.24 |
| NTHI NeOnc Technologies Holdings Inc. Common Stock | $90.77M | — | $2.7 | ▼ 1.82% | $2.5$12 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Boudreau Helen M · July 6, 2026 · Option Exercise3.6K @ $2.38
- Schneeberger Daniel · May 19, 2026 · Buy200 @ $13.8
- Schneeberger Daniel · May 19, 2026 · Buy10.0K @ $13.98
- Schneeberger Daniel · May 18, 2026 · Buy6.0K @ $13.98
- Schneeberger Daniel · May 15, 2026 · Buy200 @ $13.95
- Schneeberger Daniel · May 15, 2026 · Buy100 @ $13.8
- Schneeberger Daniel · May 13, 2026 · Buy75.2K @ $14
- Schneeberger Daniel · May 13, 2026 · Buy4.1K @ $13.8
- Schneeberger Daniel · May 12, 2026 · Buy800 @ $13.83
- Schneeberger Daniel · May 11, 2026 · Buy19.9K @ $14
- Schneeberger Daniel · May 11, 2026 · Buy25.0K @ $14
- Schneeberger Daniel · May 11, 2026 · Buy5.1K @ $14
- Schneeberger Daniel · May 5, 2026 · Buy35.1K @ $14
- Schneeberger Daniel · May 4, 2026 · Buy116.9K @ $13.97
- Schneeberger Daniel · May 4, 2026 · Buy3.9K @ $13.9
Institutional Ownership
March 31, 2026
- Total shares held
- 4.65M
- Total value held
- $41.61M
- Institutional holders
- 35
- Unknown793.5K
- Unknown524.3K
- Unknown400.0K
- Unknown378.6K
- Unknown376.6K
- Unknown302.8K
- Unknown300.6K
- Unknown300.6K
- Unknown291.8K
- Unknown191.2K
See the full, filterable feed with live charts on the MarketWall dashboard.